QA: Celgene CORP DE in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000816284_2014_Celgene_CORP_DE.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000816284, Celgene CORP DE

  xvar xval
0 AssetsCurrent 7,550,500,000
1 IntangibleAssetsNetIncludingGoodwill 4,880,900,000
2 PropertyPlantAndEquipmentNet 593,400,000
3 remainder_Assets 353,400,000
4 LiabilitiesCurrent 1,945,500,000
5 LiabilitiesNoncurrent 582,700,000
6 remainder_Liabilities 5,260,100,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,684,500,000
9 ResearchAndDevelopmentExpense 2,226,200,000
10 remainder_Expenses 1,081,400,000
11 remainder_Revenues 6,493,900,000
12 remainder_NetIncome -51,900,000
13 remainder_ComprehensiveNetIncome 143,700,000
  yvar yval
0 Assets 13,378,200,000
1 Liabilities 7,788,300,000
2 Expenses 4,992,100,000
3 Revenues 6,493,900,000
4 StockholdersEquity 5,589,900,000
5 NetIncome 1,449,900,000
6 ComprehensiveNetIncome 1,521,750,000
7 BaseVar 16,424,050,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.30
9 EconomicCapitalRatio 2.53

Edgar->Model Mapping

Feature Distribution

Change over Time